Mikhail Blagosklonny is a professor at Roswell Park institute teaching oncology. Beyond being a cancer expert, Blagosklonny is also a leading expert in the emerging science of aging, or more precisely, preventing aging. He received his medical degree and his Ph.D. in experimental medicine and cardiology from First Pavlov State Medical University. Blagosklonny eventually became the senior scientist at Ordway Research Institute in 2009, but he started his professorship as an associate professor of medicine at New York Medical College in 2002. Blagosklonny has researched such transitional topics in aging and oncology as targeted cancer therapy and general traditional cancer therapy as well as anti aging drugs and biogerontology. View Mikhail’s profile on Google Scholar
Blagosklonny is an advocate for and a pioneer in the use of the cancer drug Rapamycin as a method by which extended longevity can be achieved by mankind. Rapamycin is already a proven cancer fighting drug. In addition to Mikhail Blagosklonny’s professional endeavors in the medical field itself, he is also a medical editor in chief for two leading medical publications Cell Cycle and Oncotarget. The correlation in oncology which is the treatment and study of cancer and anti aging is in certain cancer drug’s ability to protect healthy cells either from the ravages of cancerous cells or from the treatment utilized to eradicate the cancerous cells. He asserts that TOR signaling, a therapy utilized in cancer treatment and developing successful cancer fighting drugs is also relevant to fighting the effects of aging. Visit ResearchGate.Net to know more about Mikhail’s latest work.
Mikhail Blagosklonny is a researcher, a professor, a philanthropist, as well as an average individual who wants to make sure that individuals all around the world have the best treatment possible despite their economic standing. Mikhail Blagosklonny is specifically interested in the field of medical research and has focused specifically on the study of both cancer as well as aging. Mikhail Blagosklonny is specifically interested in the connection of the two and the reason that cancer is more common in older individuals above a certain age. Mikhail Blagosklonny continues to conduct research that has and will continue to be useful within the oncology field. Mikhail Blagosklonny is an influential individual as not only a researcher, but also as a professor and an expert of his field who has been inspiration to his peers and his students who want to continue to expand on his research in the future.
The interesting topics that Mikhail Blagosklonny has picked with regards to cancer as well as aging has attracted much attention within the medical field on impactjournals.com. Mikhail Blagosklonny has the goal of figuring out a way to not only treat cancer, but to treat cancer in an effective manner that will not be excruciating and expensive as the current treatments are in present day. Mikhail Blagosklonny hopes to figure out a way in which cancerous cells can be eliminated within the body without destroying the normal cells that are specifically crucial to recovering the mind and the body after the many months or years of cancer treatment. Reference: http://www.impactjournals.com/oncotarget/index.php?journal=oncotarget&page=article&op=view&path%5B%5D=3740
Mikhail Blagosklonny has made much progress within the field of his interest and hopes that his findings will inspire other individuals around the world to pick up where he will leave off for future studies on tandfonline.com. Mikhail Blagosklonny believes that treatment for cancer, a dangerous and tragic disease, will not be a luxury treatment in the future for those with money, but will instead be an easy and cost-effective treatmenT.